


| Key | % Net Assets |
|---|---|
| 7.9% | |
| 7.7% | |
| 4.4% | |
| 4.1% | |
| 75.9% |
| Name | % Net Assets |
|---|---|
| Novartis | 7.9% |
| Roche | 7.7% |
| Koninklijke KPN | 4.4% |
| TNT | 4.1% |
| Bayer | 3.6% |
| UPM-Kymmene | 3.5% |
| Atlantia | 3.4% |
| Repsol | 3.1% |
| Thales | 3.0% |
| Elisa | 2.7% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 1,728.70p |
| Currency | GBP |
| Change | 5.33p |
| % | 0.31% |
| YTD change | 298.55p |
| YTD % | 20.88% |
| Fund Inception | 18/01/1986 |
|---|---|
| Fund Manager | Jeffrey Taylor |
| TER | 1.69 (31-Dec-2013) |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | £100 |
| Savings | £20 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.68% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.10 |
You are here: research